Catalyst
Slingshot members are tracking this event:
Bluebird Bio's(BLUE) Phase 3 data of LentiGlobin - HGB-212 Northstar-3 in TDT and the β0/β0genotype to be presented at EHA
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BLUE | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 14, 2019
Occurred Source:
http://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-presents-long-term-efficacy-and-safety-data
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Lentiglobin, Eha
